Curis, Inc. (NASDAQ:CRIS – Get Free Report) was the target of a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 1,330,000 shares, a growth of 14.7% from the August 31st total of 1,160,000 shares. Based on an average daily trading volume, of 324,500 shares, […]
Form 8-K CURIS INC For: Sep 26 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Curis, Inc. (NASDAQ:CRIS – Get Free Report) was the recipient of a significant decrease in short interest in August. As of August 31st, there was short interest totalling 1,160,000 shares, a decrease of 7.2% from the August 15th total of 1,250,000 shares. Based on an average daily trading volume, of 323,300 shares, the days-to-cover ratio […]
LEXINGTON, Mass., Sept. 6, 2023 /PRNewswire/ Curis, Inc. , a biotechnology company focused on the development of emavusertib, an orally available small molecule IRAK4 inhibitor for the treatment.
Financial Analysis: Curis (NASDAQ:CRIS) & 4D Molecular Therapeutics (NASDAQ:FDMT) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.